Abstract
The article provides an overview of sulfonylureas and meglitinides as second-line agents for treating type 2 diabetes mellitus (T2DM). Implications for occupational health clinicians who work with these individuals when they take either of these medications to achieve target glycemic indices are emphasized.
Keywords:
meglitinides; metformin; sulfonylureas; type 2 diabetes mellitus.
© 2016 The Author(s).
MeSH terms
-
Age Factors
-
Benzamides / administration & dosage*
-
Benzamides / adverse effects
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Glycemic Index
-
Humans
-
Hypoglycemic Agents / administration & dosage*
-
Hypoglycemic Agents / adverse effects
-
Metformin / administration & dosage*
-
Metformin / adverse effects
-
Occupational Health
-
Occupational Health Nursing / methods*
-
Sulfonylurea Compounds / administration & dosage*
-
Sulfonylurea Compounds / adverse effects
Substances
-
Benzamides
-
Hypoglycemic Agents
-
Sulfonylurea Compounds
-
meglitinide
-
Metformin